Buscar
Mostrando ítems 31-40 de 1656
Alternativas terapéuticas actuales de las metástasis hepáticas
(Sociedad Médica de Santiago, 2008)
Medium-term protocols for in vivo evaluation of chemical modifiers of carcinogenesis
(Instituto Oswaldo Cruz, Ministério da Saúde, 2014)
Hepatocellular carcinoma and food contamination: Ochratoxin A as a great prompter
(Baishideng Publ Grp Co Ltd, 2013-06-28)
Ochratoxin A (OTA) is a secondary metabolite of Aspergillus and Penicillium, microorganisms that can be hazardous to health when present as food contaminants. OTA is a potent member of a group of mycotoxins. Prolonged ...
Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations
(BioMed Central, 2015-07)
BACKGROUND: The global burden of chronic liver disease is rising. Besides environmental, behavioral, viral and metabolic factors, genetic polymorphisms in patatin-like phospholipase-3 (PNPLA3) and vitamin D receptor (VDR) ...
Hepatic carboxylesterase 3 (Ces3/Tgh) is downregulated in the early stages of liver cancer development in the rat
(Elsevier Science, 2016-11)
It is accepted that cancer development is associated with metabolic changes. Previously, we established a model of hepatic preneoplasia in which adult rats were subjected to a 2-phase model of hepatocarcinogenesis ...
DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center
(BioMed Central, 2018)
REEVALUATING THE AGNOR STAINING RESPONSE IN TRITON X-100-TREATED LIVER-CELLS BY IMAGE-ANALYSIS
(Elsevier Sci Publ Ireland LtdClareIrlanda, 1995)